Bulk RNA测序鉴定瘢痕疙瘩线粒体与程序性细胞死亡生物标志物
本研究对12例瘢痕疙瘩与12例对照样本行Bulk RNA测序,整合差异基因、WGCNA模块基因、程序性细胞死亡相关基因及线粒体相关基因,经两种机器学习方法筛选出UQCRC1、PRDX4和PDK2三个候选生物标志物,并预测miRNA、转录因子、免疫细胞浸润及双酚A分子对接。结论仅基于生物信息学分析,无体外或体内实验验证。
要点
- UQCRC1、PRDX4和PDK2被鉴定为瘢痕疙瘩候选生物标志物。
- 三个标志物均参与氧化磷酸化和核糖体功能。
- 结论仅基于生物信息学分析,尚属假设,需实验验证。
核心结论
- UQCRC1、PRDX4和PDK2为瘢痕疙瘩候选生物标志物,为阐明线粒体与程序性细胞死亡调控机制提供理论支持。
- 所有结论仅基于生物信息学分析,无体外或体内实验验证,尚属假设,需未来研究严格确认。
研究设计与样本
- 基于24例样本(12例瘢痕疙瘩 vs 12例对照)的初步探索性研究,行Bulk RNA测序。
- 候选基因来自差异表达基因、WGCNA模块基因、程序性细胞死亡相关基因和线粒体相关基因。
- 采用两种互补的机器学习方法筛选生物标志物,无独立外部验证。
主要发现
- 鉴定出三个生物标志物,均参与氧化磷酸化和核糖体功能。
- 预测4个miRNA和10个转录因子;PRDX4预测6个转录因子,PDK2预测58个miRNA和10个转录因子。
- 瘢痕疙瘩组与对照组间存在六种差异浸润免疫细胞,如中枢记忆CD8+ T细胞。
- 分子对接显示双酚A对生物标志物有强结合亲和力,但因其多系统毒性无直接临床治疗价值,仅作为机制研究的结构探针。
临床怎么用
- 本研究为生物信息学探索,三个候选标志物尚不能用于临床诊断或治疗决策。
- 双酚A仅可作为机制研究的结构探针,不应视为治疗候选物。
局限性
- 样本量有限(24例),无独立外部验证。
- 所有结论仅基于生物信息学分析,无体外或体内实验验证。
- 发现尚属假设,需未来研究严格确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The treatment of keloids (KD) remains challenging. This study focuses on the interplay between mitochondrial dynamics with programmed cell death (PCD) mechanisms in KD. METHODS: Bulk RNA sequencing was performed to identify differentially expressed genes (DEGs) and to investigate the most relevant module genes between KD and control samples. Candidate genes were derived from DEGs, weighted gene co-expression network analysis module genes, PCD-related genes, and mitochondria-related genes. Screening employed two complementary machine learning-based approaches to pinpoint KD biomarkers, followed by comprehensive characterization of their biological functions, network properties, and drug interaction potential. Finally, the differentially infiltrated immune cells in the KD group were analyzed. MAIN FINDINGS: In this preliminary exploratory study based on 24 samples (12 KD vs. 12 controls) without independent external validation, three biomarkers were identified. All biomarkers were involved in oxidative phosphorylation and ribosome function. Subsequently, 4 miRNAs and 10 transcription factors (TFs) were predicted; 6 TFs were predicted by PRDX4, and 58 miRNAs and 10 TFs were predicted by PDK2. In addition, there were six different immune cells in the KD and control groups, such as central memory CD8+ T cells. Finally, bisphenol A demonstrated strong binding affinity for the biomarkers in molecular docking. However, due to its well-documented multisystem toxicity, it has no direct clinical therapeutic value. Therefore, bisphenol A should be considered solely as a structural probe for mechanistic studies rather than a therapeutic candidate. CONCLUSION: This study identified UQCRC1, PRDX4, and PDK2 as candidate biomarkers for keloids (KD), providing theoretical support for elucidating the regulatory mechanisms of mitochondria and programmed cell death in keloids. All conclusions were based solely on bioinformatic analyses without in vitro or in vivo experimental validation, thus the findings remain hypothetical and require rigorous confirmation in future studies.
引用
- Li S, Wei F, Zhang L, et al. Bulk RNA sequencing identifies biomarkers for mitochondrial and programmed cell death in keloids. Burns. 2026. PMID: 42314404. doi:10.1016/j.burns.2026.108029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。